Implantable theranostic devices allow controlling the applied therapy and monitoring the disease progression in order to achieve highly personalized medical care. These devices perform increasingly sophisticated sensing, computation, and actuation in a closed loop manner. Examples include drug delivery systems, pacemakers, implantable cardiac defibrillators, neurostimulators or glycaemic control systems.
The DGBMT Expert Survey 2017 has identified emerging implantable theranostic devices as well as key experts, market players and issues in the field. In addition, the study has analysed technical and non-technical factors that have an impact on the development of these special medical devices.
The results are now available upon request for free.
Participants of the survey had been invited to take part in a drawing of a free participation at the forthcoming course “Hands-on-Intensivkurs für Ingenieure: Chirurgie in der Praxis” in Munich and a winner has been contacted.